Evolution of Lung Cancer in the Context of Immunotherapy
Sheng Yu, Ruilin Wang, Hong Tang, Lili Wang, Zhe Zhang, Sen Yang, Shuyue Jiao, Xuan Wu, Shuai Wang, Mingyue Wang, Cong Xu, Qiming Wang, Yufeng Wu
Abstract
Immunotherapy, as a novel treatment, has brought new hope to many patients with cancer, including patients with lung cancer. However, the overall cure rate and survival rate of lung cancer are still not satisfactory. The process of evolution has improved the ability of tumors to adapt to immunotherapy, which induces drug resistance. Many studies have focused on immunoresistance and achieved meaningful results. Therefore, it is necessary to have an in-depth understanding of the current research progress in immunoresistance, which will help to achieve good clinical results more efficiently.
Topics & Concepts
ImmunotherapyLung cancerMedicineContext (archaeology)CancerCure rateIntensive care medicineOncologyInternal medicineBiologyPaleontologyImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersCAR-T cell therapy research